IPO
-
-
-
-
-
-
-
Xeris Pharmaceuticals to Participate at SVB Leerink Global Healthcare Conference
-
-
-
-
-
-
-
Xeris Pharmaceuticals to Present at Two Upcoming Investor Conferences
-
-
-
-
-
-
-
Xeris Pharmaceuticals (XERS) Reports Positive Phase 3 Clinical Trial Data on Its Investigational Ready-to-Use Glucagon Rescue Pen
-
-
-
-
-
98,788 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All